skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms

Journal Article · · Toxicology and Applied Pharmacology
 [1]; ; ;  [1];  [2]; ;  [3];  [1];  [4]
  1. Section of Toxicology and Biomedical Sciences, ENEA Research Center, Casaccia, Via Anguillarese 301, 00060, Rome (Italy)
  2. Fondazione Don Carlo Gnocchi, Via Maresciallo Caviglia 30, 00194, Rome (Italy)
  3. Occupational Hygiene Department, Institute for Occupational Health and Safety, Rome (Italy)
  4. Department of Biology, University of Rome 'Roma Tre', Viale Marconi 446, 00146, Rome (Italy)

The aim of our study was to investigate whether occupational exposure to antineoplastic drugs (AND) resulted in genetic damage, possibly indicative of adverse health effects in the long term. We performed a chromosomal aberrations (CA) analysis in peripheral blood lymphocytes (PBL) of a group of 76 trained nurses occupationally exposed to AND. Furthermore, we analysed whether genetic polymorphisms in four metabolic genes of the glutathione S-transferase (GST) family involved in antineoplastic drugs detoxification (GSTM1, GSTT1, GSTP1, GSTA1) had any effect on the yield of chromosomal aberrations in nurses exposed to antineoplastic agents. The exposed group showed a very significant increase of genetic damage (p < 0.0001) potentially indicative of an increased risk of cancer. Unexpectedly, besides the elevated level of chromatid-type aberrations usually related to exposure to chemical agents, we found also severe chromosome damages such as chromosome deletions and dicentric chromosomes, usually related to radiation exposure. No significant association was detected between all GSTs genotypes and chromosome damage. In conclusion, our data show how the occupational exposure to AND is associated to a potential cancer risk, suggesting that current prevention methods do not completely eliminate opportunities for exposure and supporting the need to improve the actual safety practices.

OSTI ID:
21077779
Journal Information:
Toxicology and Applied Pharmacology, Vol. 223, Issue 1; Other Information: DOI: 10.1016/j.taap.2007.05.006; PII: S0041-008X(07)00228-1; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English